Biotech stocks find themselves in a very interesting, and potentially very profitable, situation right now.
It’s widely believed by public health officials that we can’t return to “normal” until scientists discover a coronavirus vaccine that can be widely distributed.
The U.S. government is investing billions of dollars in biotech companies to develop a COVID-19 vaccine as quickly as possible – so the world can return to normal.
But not all biotech stocks are worth buying right now.
Money Morning Quantitative Trading Specialist Chris Johnson conducted his own fundamental and technical analysis to uncover six biotech stocks that he thinks have the highest probability of putting profits in your pocket right now.
In the short video below from earlier today, Chris reveals three biotech stocks to buy… and three to avoid.
He even gives some long-term options (LEAPS) trade ideas that could make you a lot more money than owning the underlying stock too.
If you’re looking to make some fast money in the biotech sector, watch this…
Chris’ 6 “High Conviction” Biotech Stocks to Trade Now
— Money Morning Staff
Source: Money Morning